Adnan Al‐Lahham
Impact in
- Microbiology top 1%
- Bacterial Infections and Vaccines
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
Papers in
- Epidemiology 36
- Pneumonia and Respiratory Infections 34
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Respiratory viral infections research 8
-
- Antimicrobial Resistance in Staphylococcus 20
- Co-authors
- Ralf René Reinert (29 shared papers)Mark van der Linden (16 shared papers)Murat Cil (6 shared papers)Rudolf Lütticken (10 shared papers)Peter C. Appelbaum (4 shared papers)A. Bryskier (2 shared papers)Ioanna N. Grivea (3 shared papers)George A. Syrogiannopoulos (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Journal of Clinical Microbiology (4 papers)PLoS ONE (4 papers)Clinical Microbiology and Infection (3 papers)Chemotherapy (3 papers)
- Partner nations
- GermanyJordanUnited States
In The Last Decade
Adnan Al‐Lahham
41 papers receiving 970 citations
Peers
Comparison fields: 5 of 67
- Microbiology 311
- Infectious Diseases 411
- Molecular Medicine 101
- Epidemiology 688
- Applied Microbiology and Biotechnology 35
Countries citing papers authored by Adnan Al‐Lahham
This map shows the geographic impact of Adnan Al‐Lahham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Al‐Lahham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Al‐Lahham more than expected).
Fields of papers citing papers by Adnan Al‐Lahham
This network shows the impact of papers produced by Adnan Al‐Lahham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Al‐Lahham. The network helps show where Adnan Al‐Lahham may publish in the future.
Co-authors
The 25 scholars most cited alongside Adnan Al‐Lahham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 124 | |
| 2 | 2003 | 76 | |
| 3 | 2011 | 68 | |
| 4 | 2005 | 62 | |
| 5 | 2005 | 56 | |
| 6 | 2003 | 46 | |
| 7 | 2005 | 44 | |
| 8 | 2001 | 44 | |
| 9 | 2010 | 38 | |
| 10 | 2004 | 36 | |
| 11 | 2002 | 34 | |
| 12 | 2004 | 33 | |
| 13 | 2004 | 31 | |
| 14 | 1999 | 26 | |
| 15 | 2007 | 26 | |
| 16 | 2013 | 21 | |
| 17 | 2006 | 19 | |
| 18 | 2008 | 19 | |
| 19 | 2005 | 19 | |
| 20 | 2007 | 17 |
About Adnan Al‐Lahham
Adnan Al‐Lahham is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Microbiology and Pharmacology, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (34 papers), Antimicrobial Resistance in Staphylococcus (20 papers), Streptococcal Infections and Treatments (15 papers), Bacterial Infections and Vaccines (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Respiratory viral infections research (8 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Microbiology (311 citations), Infectious Diseases (411 citations), Molecular Medicine (101 citations), Epidemiology (688 citations) and Applied Microbiology and Biotechnology (35 citations). Adnan Al‐Lahham has collaborated with scholars based in Germany, Jordan and United States. Frequent co-authors include Ralf René Reinert, Mark van der Linden, Murat Cil, Rudolf Lütticken, Peter C. Appelbaum, A. Bryskier, Ioanna N. Grivea, George A. Syrogiannopoulos, Lothar Rink and Anette Siedler. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, PLoS ONE, Clinical Microbiology and Infection and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.